Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry

被引:30
作者
Tai, Susan S. -C. [1 ]
Yeh, Chia-Yi
Phinney, Karen W. [1 ]
机构
[1] Natl Inst Stand & Technol, Div Analyt Chem, Gaithersburg, MD 20899 USA
关键词
Antiepileptic drugs; Reference measurement procedure; Electrospray ionization; Isotope dilution; Liquid chromatography/tandem mass spectrometry; Solid-phase extraction; HUMAN PLASMA; DRUGS; METABOLITES; EXTRACTION; ZONISAMIDE;
D O I
10.1007/s00216-011-5251-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Phenytoin (PHT), phenobarbital (PHB), lamotrigine (LTG), and topiramate (TPM) are some of the most widely used antiepileptic drugs (AEDs). Monitoring of their concentrations in serum is important for the treatment of epilepsy. A reference measurement procedure (RMP) for certification of PHT, PHB, LTG, and TPM in serum has been developed and critically evaluated. Isotopically labeled compounds of PHT, PHB, LTG, and TPM are used as internal standards for the four AEDs. The four drugs and their respective labeled internal standards are simultaneously extracted from serum using solid-phase extraction prior to reversed-phase liquid chromatography-tandem mass spectrometry (LC-MS/MS). Chromatographic separation was performed using a C-18 column. Electrospray ionization (ESI) in the positive ion mode for PHT and LTG, and in the negative ion mode for PHB and TPM were used. The recovery of AEDs added to serum (accuracy of the extraction method) was evaluated by recovery studies of measuring the four drugs in spiked samples with known drug levels. The recoveries of the added drugs ranged from 98.6% to 102.0%. The absolute recoveries (extraction efficiencies) of the four drugs with this method ranged from 97% to 100%. Excellent repeatability was obtained for the four drugs with between-set coefficients of variation (CVs) within 1%. The type B components estimates are conservatively large and are considerably larger than the type A component. Therefore, we use the usual metrological expansion factor of 2 to provide an approximate 95% coverage interval. The relative expanded uncertainties for the four AEDs ranged from 2.3% to 2.4%. This LC-MS/MS RMP for PHT, PHB, LTG, and TPM in serum demonstrating good accuracy and precision can be used to assess the accuracy of routine methods used in clinical laboratories.
引用
收藏
页码:1915 / 1922
页数:8
相关论文
共 31 条
[1]  
[Anonymous], 2003, 15193 ISO
[2]   Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry [J].
Beck, Olof ;
Ohman, Inger ;
Nordgren, Helena K. .
THERAPEUTIC DRUG MONITORING, 2006, 28 (05) :603-607
[3]   Pharmacokinetics and metabolism of topiramate [J].
Bourgeois, BFD .
DRUGS OF TODAY, 1999, 35 (01) :43-48
[4]   Analysis of topiramate and its metabolites in plasma and urine of healthy subjects and patients with epilepsy by use of a novel liquid chromatography-mass spectrometry assay [J].
Britzi, M ;
Soback, S ;
Isoherranen, N ;
Levy, RH ;
Perucca, E ;
Doose, DR ;
Maryanoff, BE ;
Bialer, M .
THERAPEUTIC DRUG MONITORING, 2003, 25 (03) :314-322
[5]   In-source fragmentation of an isobaric impurity of lamotrigine for its measurement by liquid chromatography tandem mass spectrometry after pre-concentration using solid phase extraction [J].
Carrier, Dan J. ;
Eckers, Christine ;
Wolff, Jean-Claude .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 47 (4-5) :731-737
[6]  
Chen S, 1999, RAPID COMMUN MASS SP, V13, P1980, DOI 10.1002/(SICI)1097-0231(19991030)13:20<1980::AID-RCM741>3.0.CO
[7]  
2-C
[8]   Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: Validation and comparison with fluorescence-polarization immunoassay [J].
Christensen, J ;
Hojskov, CS ;
Poulsen, JH .
THERAPEUTIC DRUG MONITORING, 2002, 24 (05) :658-664
[9]  
Ellison SLR, 2009, PRACTICAL STATISTICS FOR THE ANALYTICAL SCIENTIST: A BENCH GUIDE, SECOND EDITION, P1
[10]   GAS-CHROMATOGRAPHIC SCREENING-PROCEDURE FOR ACID AND NEUTRAL-DRUGS IN BLOOD [J].
FOERSTER, EH ;
DEMPSEY, J ;
GARRIOTT, JC .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1979, 3 (03) :87-91